BSEBrawn Biotech LtdLowNeutral
Announced Wed, 25 Mar · 11:58 IST

Appointment of Internal Auditors and Secretarial Auditor for FY 2025-26.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.7%1-day move
₹21.00
prior close
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-5.7-4.8+6.7-4.1+8.0
Up moveDown movePending
AI summary

Brawn Biotech Ltd's Board of Directors, at a meeting held on 25th March 2026, approved two appointments for the financial year 2025-26. First, Mr. Viney, a Practicing Company Secretary (COP No. 28263), was appointed as the Secretarial Auditor. Second, M/s Sahil Pasricha & Associates, a Chartered Accountant firm (FRN: 026379N), was appointed as the Internal Auditor. Both appointments were made on the recommendation of the Audit Committee and are effective from 25th March 2026. The brief profiles of both appointees were annexed to the filing as required under SEBI LODR Regulations.

Likely market impact

This is a routine corporate governance and compliance action with no direct impact on shareholders or the stock price. It reflects the company meeting its statutory audit and compliance requirements for FY 2025-26.